Riya Life Sciences Private Limited
Medical goods trading and distribution company based in Delhi.
2017 | Delhi (India) | Active
Riya Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 4190.58%
- Profit Growth 1776.42%
- Ebitda 2330.28%
- Net Worth 317.84%
- Total Assets 2220.42%
About Riya Life Sciences
Riya Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 2017 (Seven years and seven months 30 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Puneet Jindal and Reena Jindal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2017PTC319987
- Company No.
319987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jun 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Who are the key members and board of directors at Riya Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Puneet Jindal  | Director | 30-Jun-2017 | Current |
| Reena Jindal | Director | 30-Jun-2017 | Current |
Financial Performance of Riya Life Sciences.
Riya Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4190.58% increase. The company also saw a substantial improvement in profitability, with a 1776.42% increase in profit. The company's net worth Soared by an impressive increase of 317.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riya Life Sciences?
Unlock access to Riya Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Riya Life Sciences?
Unlock and access historical data on people associated with Riya Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riya Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riya Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.